Demars Financial Group, LLC Merck & Co., Inc. Transaction History

Demars Financial Group, LLC

$3.11 Billion
Q4 2024

A detailed history of Demars Financial Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Demars Financial Group, LLC holds 652,231 shares of MRK stock, worth $58.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

652,231

Previous 7,402 8711.55%

Holding current value

$58.4 Million

Previous $840,000 680.48%

% of portfolio

0.21%

Previous 0.39%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$96.31 - $114.76 $62.1 Million - $74 Million	644,829 Added 8711.55%	652,231 $6.56 Million
Q3 2024 Nov 01, 2024	SELL	$111.15 - $128.97 $2,111 - $2,450	-19 Reduced 0.26%	7,402 $840,000
Q2 2024 Jul 19, 2024	SELL	$123.8 - $132.96 $25,750 - $27,655	-208 Reduced 2.73%	7,421 $918,000
Q1 2024 Apr 24, 2024	SELL	$113.24 - $131.95 $608,438 - $708,967	-5,373 Reduced 41.32%	7,629 $1.01 Million
Q4 2023 Feb 01, 2024	SELL	$100.18 - $109.02 $3.43 Million - $3.73 Million	-34,212 Reduced 72.46%	13,002 $1.42 Million
Q3 2023 Oct 18, 2023	SELL	$102.95 - $114.33 $83,595 - $92,835	-812 Reduced 1.69%	47,214 $4.86 Million
Q2 2023 Jul 20, 2023	SELL	$108.61 - $118.38 $148,144 - $161,470	-1,364 Reduced 2.76%	48,026 $5.54 Million
Q1 2023 Apr 20, 2023	SELL	$102.94 - $114.86 $139,174 - $155,290	-1,352 Reduced 2.66%	49,390 $5.25 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $658,423 - $844,188	-7,530 Reduced 12.92%	50,742 $5.63 Million
Q3 2022 Oct 21, 2022	SELL	$84.53 - $94.96 $273,285 - $307,005	-3,233 Reduced 5.26%	58,272 $5.02 Million
Q2 2022 Jul 22, 2022	BUY	$83.49 - $94.64 $4.19 Million - $4.75 Million	50,199 Added 444.0%	61,505 $5.61 Million
Q1 2022 Apr 27, 2022	BUY	$73.51 - $82.4 $9,997 - $11,206	136 Added 1.22%	11,306 $928,000
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $95,698 - $119,874	1,324 Added 13.45%	11,170 $856,000
Q3 2021 Oct 15, 2021	BUY	$71.68 - $78.83 $262,277 - $288,438	3,659 Added 59.14%	9,846 $740,000
Q2 2021 Jul 16, 2021	BUY	$70.31 - $77.77 $136,542 - $151,029	1,942 Added 45.75%	6,187 $481,000
Q1 2021 Apr 13, 2021	SELL	$68.86 - $81.11 $55,088 - $64,888	-800 Reduced 15.86%	4,245 $327,000
Q4 2020 Jan 25, 2021	SELL	$71.77 - $79.65 $2.69 Million - $2.99 Million	-37,534 Reduced 88.15%	5,045 $413,000
Q3 2020 Oct 21, 2020	BUY	$73.18 - $82.95 $37,760 - $42,802	516 Added 1.23%	42,579 $3.53 Million
Q2 2020 Sep 15, 2020	SELL	$70.42 - $80.13 $26.7 Million - $30.3 Million	-378,569 Reduced 90.0%	42,063 $3.25 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $26.8 Million - $30.5 Million	380,701 Added 953.4%	420,632 $3.25 Million
Q1 2020 Apr 27, 2020	BUY	$63.36 - $87.82 $63,550 - $88,083	1,003 Added 2.58%	39,931 $3.07 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $3.02 Million - $3.41 Million	38,928 New	38,928 $3.54 Million

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Demars Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Demars Financial Group, LLC with notifications on news.

Account

Demars Financial Group, LLC Merck & Co., Inc. Transaction History